|
⚲
|
| Keyboard |
| William Radvak | |
|---|---|
| Firm | |
| Address | Suite 1703 595 Burrard Street Vancouver, A1 V7X 1J1 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Regency Gold Corp | 021-361103 | Executive Officer | 1.7 M of 3.0 M |
||
| Nervgen Pharma Corp | 021-335393 | Executive Officer | 1.2 M of 1.2 M |
||
| Nervgen Pharma Corp | 021-321779 | Executive Officer | 0.1 M of 0.1 M |
||
| American Vanadium Corp | 021-256657 | Executive Officer | 0.0 M of 0.0 M |
||
| American Vanadium Corp | 021-239241 | Executive Officer | 0.0 M of 0.0 M |
||
| American Vanadium Corp | 021-217672 | Executive Officer | 0.2 M of 0.3 M |
||
| American Vanadium Corp | 021-204391 | Executive Officer | 0.1 M of 18.7 M |
||
| American Vanadium Corp | 021-195144 | Executive Officer | 0.1 M of 0.1 M |
||
| American Vanadium Corp | 021-189196 | Executive Officer | 0.1 M of 0.1 M |
||
| American Vanadium Corp | 021-184517 | Executive Officer | 0.4 M of 0.8 M |
||
| American Vanadium Corp | 021-157752 | Executive Officer | 0.2 M of 0.4 M |
||